TECHNOLOGY CO-DEVELOPMENT AGREEMENTTechnology Co-Development Agreement • December 27th, 2021 • Microbot Medical Inc. • Biological products, (no disgnostic substances) • New York
This TECHNOLOGY CO-DEVELOPMENT AGREEMENT (the “Agreement”) is made effective as of the date of last signature (the “Effective Date”) by and between Microbot Medical, Inc., a Delaware corporation with a place of business located at 25 Recreation Park Drive, Suite 108, Hingham, MA 02043, on behalf of itself and its Affiliates (“Microbot”), and Stryker Corporation, acting through its Neurovascular Division, a Michigan corporation with a place of business at 47900 Bayside Parkway, Fremont, CA 94538 (“Stryker”). Stryker and Microbot are referred to herein as either a “Party” individually, or as the “Parties” collectively.
